Production Method 1

121521-90-2

96574-01-5

Reaction Conditions

1.1 Reagents: Acetic acid Solvents: Dimethylformamide ,  Water ;  3.5 h, 120 °C

Reference

Method for preparing salvianolic acid A

, China, , ,

Salvianolic acid A Raw materials

• Salvianolic acid B

Salvianolic acid A Preparation Products

• Salvianolic acid A (96574-01-5)

• 1. An atomic scale study of defects in Co2FeAl
  Ravi Kumar Yadav,R. Govindaraj Phys. Chem. Chem. Phys., 2020,22, 26876-26886
• 2. Acetyl group orientation modulates the electronic ground-state asymmetry of the special pair in purple bacterial reaction centers
  P. K. Wawrzyniak,M. T. P. Beerepoot,H. J. M. de Groot,F. Buda Phys. Chem. Chem. Phys., 2011,13, 10270-10279
• 3. Aluminium complexes with thio-phosphorus ligands: syntheses and characterisations of [Al2(CyPS3)2(CyPHS2)2] and [Al(S2PPh2)3]?
  Robert P. Davies,Maria A. Giménez,Laura Patel,Andrew J. P. White Dalton Trans., 2008, 5705-5707
• 4. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
• 5. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381

• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Stilbenes Stilbenes
• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Stilbenes
• Solvents and Organic Chemicals Organic Compounds Acids/Esters

Introduction to Salvianolic acid A (CAS No: 96574-01-5)

Salvianolic acid A, a naturally occurring compound with the chemical formula C₁₅H₁₀O₇, is a derivative of rosmarinic acid and has garnered significant attention in the field of pharmaceutical chemistry and medicinal biology. This compound, identified by its CAS number 96574-01-5, is primarily extracted from the dried leaves of Salvia miltiorrhiza, a plant traditionally used in Chinese medicine for its therapeutic properties. The extensive research on Salvianolic acid A has revealed its multifaceted biological activities, making it a subject of intense study in both academic and industrial settings.

The pharmacological properties of Salvianolic acid A have been extensively explored, particularly for its potential applications in cardiovascular health, neuroprotection, and anti-inflammatory effects. Recent studies have highlighted its role in modulating various cellular pathways, which contribute to its therapeutic benefits. For instance, research has demonstrated that Salvianolic acid A can inhibit the production of reactive oxygen species (ROS) and reduce oxidative stress, thereby protecting cells from damage caused by free radicals.

In the realm of cardiovascular research, Salvianolic acid A has shown promise in preventing atherosclerosis and improving endothelial function. Studies have indicated that this compound can enhance the synthesis of nitric oxide (NO), a crucial molecule for vasodilation and maintaining vascular health. Furthermore, Salvianolic acid A has been found to exert antiplatelet effects, reducing the risk of thrombus formation and thus preventing cardiovascular events.

The neuroprotective properties of Salvianolic acid A have also been a focus of recent investigations. Preclinical studies suggest that this compound can protect against neurodegenerative diseases such as Alzheimer's and Parkinson's by inhibiting the aggregation of amyloid-beta plaques and tau proteins. Additionally, Salvianolic acid A has demonstrated antioxidant and anti-inflammatory effects in neuronal cells, which are believed to contribute to its neuroprotective capabilities.

Beyond its cardiovascular and neuroprotective roles, Salvianolic acid A has been studied for its anti-inflammatory effects. Research has shown that this compound can modulate the expression of pro-inflammatory cytokines such as TNF-alpha and IL-6, thereby reducing inflammation in various tissues. These findings suggest that Salvianolic acid A could be a valuable therapeutic agent for conditions characterized by chronic inflammation.

The molecular mechanisms underlying the biological activities of Salvianolic acid A are also areas of active research. Studies have identified several targets through which this compound exerts its effects, including enzymes involved in lipid metabolism, signaling pathways related to cell survival, and receptors mediating inflammatory responses. Understanding these mechanisms not only enhances our knowledge of Salvianolic acid A's pharmacology but also provides insights into potential drug development strategies.

In conclusion, the multifaceted biological activities of Salvianolic acid A, as evidenced by recent research, underscore its significance as a natural product with therapeutic potential. Its ability to modulate various cellular pathways makes it a promising candidate for the development of new drugs targeting cardiovascular diseases, neurodegenerative disorders, and inflammatory conditions. As further studies continue to elucidate its mechanisms of action and therapeutic efficacy, Salvianolic acid A(CAS No: 96574-01-5) is poised to play an increasingly important role in modern medicine.

• 537-15-5(Rosmarinic acid)
• 121521-90-2(Salvianolic acid B)
• 115841-09-3(Salvianolic acid C)
• 142115-17-1(Benzenepropanoic acid,3,4-dihydroxy-a-[[(2E)-1-oxo-3-(4,7,8-trihydroxydibenz[b,f]oxepin-1-yl)-2-propen-1-yl]oxy]-,(aR)-)
• 99353-00-1(Methyl rosmarinate)
• 142998-47-8(Salvianolic acid D)
• 1015171-69-3(Methyl salvionolate A)
• 115939-25-8(Salvianolic acid B)
• 20283-92-5(Rosmarinic acid)
• 142998-46-7(Salvianolic acid E)